By Sydney Kodatsky | Saturday, July 17, 2021 - 7:09am
On Wednesday, July 14 the Canadian Answering TTP Community was introduced to our new consultants that we have engaged to support our battle for access to caplacizumab in provinces across Canada.
Andrew provided an overview of important advocacy principles, context and considerations for advocacy, and a quick preliminary peak at our government advocacy plans for the months ahead as we continue our journey towards achieving publicly-funded access to treatment with caplacizumab. Click here to view the recording if you missed it. Enter the password "z%gs9rNn" when prompted.
Please register for the next session on Wednesday August 11 here. Everyone is welcome and encouraged to attend. Don't worry if this will be your first session. We will catch you up. Access to caplacizumab for patients in Canada will require effort in every jurisdiction. We need your help, and you can tailor your commitment to suit your schedule. From a few clicks to a meeting with your elected representative, every effort counts and we are developing a toolkit to tackle this together.